EPIC- Extracorporeal Photopheresis (ECP) for Immune-related Colitis

NCT06646016 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study Withdrawn by Sponsor prior to Enrollment.

Conditions

Immune-related Colitis

Interventions

DRUG: Methoxsalen
DRUG: Infliximab
DRUG: Vedolizumab

Sponsor

Therakos LLC